Improvement of restless legs syndrome and trichotillomania with aripiprazole

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 6, 2009, Pages 723-725

  Virit, O ^a   Selek, S ^a   Savas, H A ^a   Kokacya H ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Aripiprazole; Restless legs syndrome; Trichotillomania

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; REBOXETINE; TRAZODONE; VENLAFAXINE;

ADD ON THERAPY; ADULT; ANXIETY; ARTICLE; CASE REPORT; DEPRESSION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; REMISSION; RESTLESS LEGS SYNDROME; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; TRICHOTILLOMANIA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; PIPERAZINES; QUINOLONES; RESTLESS LEGS SYNDROME; TRICHOTILLOMANIA;

EID: 70450203274     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01051.x     Document Type: Article

References (16)

1. Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Movement Disorders, 10, 634 642.
2. Allen R (2004) Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Medicine, 5, 385 391.
3. Christenson GA, Mackenzie TB, Mitchell JE (1991) Characteristics of 60 adult chronic hair pullers. American Journal of Psychiatry, 148, 365 370.
4. Yokoi F, Grunder G, Biziere K et al. (2002) Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology, 27, 248 259.
5. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M (1999) The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep medicine review. Sleep, 22, 970 999.
6. Kraus T, Schuld A, Pollmacher T (1999) Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. Journal of Clinical Psychopharmacology, 19, 478 479.
7. Qu S, Ondo WG, Zhang X, Xie WJ, Pan TH, Le WD (2006) Projections of diencephalic dopamine neurons into the spinal cord in mice. Experimental Brain Research, 168, 152 156.
8. Swedo SE, Rapoport JL, Leonard HL, Schapiro MB, Rapoport SI, Grady CL (1991) Regional cerebral glucose metabolism of women with trichotillomania. Archives of General Psychiatry, 48, 828 833.
9. O'Sullivan RL, Rauch SL, Breiter HC et al. (1997) Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biological Psychiatry, 42, 39 45.
10. Bohne A, Keuthen NJ, Tuschen-Caffier B, Wilhelm S (2005) Cognitive inhibition in trichotillomania and obsessive-compulsive disorder. Behaviour Research and Therapy, 43, 923 942. (Pubitemid 40719613)
11. American Psychiatric Association (2001) Consumer and family information. Obsessive-compulsive disorder. Psychiatric Services, 52, 577.
12. Stewart RS, Nejtek VA (2003) An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. Journal of Clinical Psychiatry, 64, 49 52.
13. Srivastava RK, Sharma S, Tiwari N, Saluja B (2005) Olanzapine augmentation of fluoxetine in trichotillomania: two cases. The Australian and New Zealand Journal of Psychiatry, 39, 112 113.
14. Gabriel A (2001) A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 46, 285 286.
15. Stein DJ, Hollander E (1992) Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of Trichotillomania. Journal of Clinical Psychiatry, 53, 123 126.
16. Jefferys D, Burrows G (2008). Reversal of trichotillomania with aripiprazole. Depress Anxiety, 25, E37 40.